Quick Answer
cbdMD, Inc. reported Stockholders Equity of $7.23 million for fiscal year 2025.
cbdMD, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.23M | +268.0% |
| 2024 | $1.96M | -35.2% |
| 2024 | $3.03M | -1.9% |
| 2024 | $3.09M | -56.1% |
| 2023 | $7.04M | -22.1% |
| 2023 | $9.03M | -64.9% |
| 2023 | $25.73M | -0.2% |
| 2023 | $25.79M | -3.0% |
| 2022 | $26.59M | -15.4% |
| 2022 | $31.42M | -32.6% |
| 2022 | $46.60M | -41.8% |
| 2022 | $80.02M | -5.2% |
| 2021 | $84.40M | -18.2% |
| 2021 | $103.14M | +15.5% |
| 2021 | $89.28M | +4.0% |
| 2021 | $85.88M | +0.2% |
| 2020 | $85.72M | +8.3% |
| 2020 | $79.18M | -5.3% |
| 2020 | $83.58M | -9.3% |
| 2020 | $92.16M | +66.0% |
| 2019 | $55.52M | +47.7% |
| 2019 | $37.60M | +49.5% |
| 2019 | $25.15M | +286.9% |
| 2019 | -$13.45M | -174.2% |
| 2018 | $18.13M | +29.3% |
| 2018 | $14.02M | -7.9% |
| 2018 | $15.22M | +0.1% |
| 2018 | $15.20M | +7.4% |
| 2017 | $14.16M | +236.1% |
| 2017 | $4.21M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $9.01M | +405.6% | +24.7% |
| September 30, 2025 | $7.23M | +268.0% | +18.3% |
| June 30, 2025 | $6.11M | +101.8% | +817.8% |
| March 31, 2025 | $665.8K | -78.4% | -62.6% |
| December 31, 2024 | $1.78M | -74.7% | -9.3% |
| September 30, 2024 | $1.96M | -78.3% | -35.2% |
| June 30, 2024 | $3.03M | -88.2% | -1.9% |
| March 31, 2024 | $3.09M | -88.0% | -56.1% |
- cbdMD, Inc. showed an increase of +268.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, cbdMD, Inc.’s stockholders equity has grown by 71.6% (from $4.21 million to $7.23 million).
- The most recent figure is from cbdMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: